Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

NCT04487717 is registered in ClinicalTrials.gov with Novomics. Co., Ltd. as lead sponsor.

NCT NCT04487717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04487717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
Lead sponsor
Novomics. Co., Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
July 29, 2020
Completion date
December 31, 2029
Enrollment
581 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer